Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Symptoms Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases Visual Performance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Player/ Coach must answer "Yes" to the survey eligibility question.
Player/Coach must voluntarily agree to participate in survey

Exclusion criteria

None.

Treatment and study plan

Systane® Ultra

Other

Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3%

Primary outcomes

Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session

Time frame: 60 minutes post-dosing with test article

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start: 2009
Primary completion: 2009
First posted: Jul 14, 2009
Registry last updated: Feb 9, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting